Inventor · disambiguated record
Zecheng Chen
Also filed as: CHEN ZECHENG
12 granted patents·9 pending applications·73 citations·filing 2008–2023
90Inventor score
Top patents by PatentIndex Score
21 records- 0192US8039469B2Triazine compounds as PI3 kinase and mTOR inhibitorsWYETH LLC·Filed 2009·Granted Oct 18, 2011·15 cites·17 claims
- 0291US10022381B2Triazine compounds as PI3 kinase and mTOR inhibitorsWYETH LLC·Filed 2015·Granted Jul 17, 2018·5 cites·6 claims
- 0391US8748421B2Triazine compounds as P13 kinase and MTOR inhibitorsWYETH LLC·Filed 2013·Granted Jun 10, 2014·11 cites·9 claims
- 0489US8859542B2Triazine compounds as PI3 kinase and mTOR inhibitorsWYETH LLC·Filed 2014·Granted Oct 14, 2014·9 cites·12 claims
- 0589US8575159B2Triazine compounds as PI3 kinase and mTOR inhibitorsPFIZER·Filed 2012·Granted Nov 5, 2013·9 cites·21 claims
- 0689US8217036B2Triazine compounds as PI3 kinase and mTOR inhibitorsVENKATESAN ARANAPAKAM MUDUMBAI·Filed 2011·Granted Jul 10, 2012·12 cites·10 claims
- 0785US9174963B2Triazine compounds as PI3 kinase and MTOR inhibitorsWYETH LLC·Filed 2014·Granted Nov 3, 2015·5 cites·2 claims
- 0884US8445486B2Triazine compounds as PI3 kinase and mTOR inhibitorsVENKATESAN ARANAPAKAM MUDUMBAI·Filed 2012·Granted May 21, 2013·5 cites·10 claims
- 0973US10086085B2Bifunctional cytotoxic agentsPFIZER·Filed 2015·Granted Oct 2, 2018·2 cites·13 claims
- 1062US2024181028A1Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereofPFIZER·Filed 2023·Application pending·0 cites
- 1161US11365263B2Bifunctional cytotoxic agents containing the CTI pharmacophorePFIZER·Filed 2020·Granted Jun 21, 2022·0 cites·4 claims
- 1258US2023383324A1Methods for purifying bacterial polysaccharidesPFIZER·Filed 2021·Application pending·0 cites
- 1355US2010003250A1(2-aryl-7h-pyrrolo[2,3-d]pyrimidin-4-yl)morpholine compounds, their use as mtor kinase and pi3 kinase inhibitors, and their synthesesWYETH CORP·Filed 2009·Application pending·0 cites
- 1454US10870706B2Bifunctional cytotoxic agents containing the CTI pharmacophorePFIZER·Filed 2016·Granted Dec 22, 2020·0 cites·19 claims
- 1554US2010036123A1Process for the preparation of 2,4-dichloro-7h-pyrrolo[2,3h]quinazolineWYETH CORP·Filed 2009·Application pending·0 cites
- 1651US2009004185A1Amino-substituted quinazoline derivatives as inhibitors of beta-catenin/tcf-4 pathway and cancer treatment agentsWYETH CORP·Filed 2008·Application pending·0 cites
- 1751US2009181963A13H-[1,2,3]TRIAZOLO[4,5-D]PYRIMIDINE COMPOUNDS, THEIR USE AS mTOR KINASE AND PI3 KINASE INHIBITORS, AND THEIR SYNTHESESWYETH CORP·Filed 2009·Application pending·0 cites
- 1850US2009227575A17H-PYRROLO[2,3-H]QUINAZOLINE COMPOUNDS, THEIR USE AS mTOR KINASE AND PI3 KINASE INHIBITORS, AND THEIR SYNTHESISWYETH CORP·Filed 2009·Application pending·0 cites
- 1949US2009149458A1PYRROLO[3,2-d]PYRIMIDINE COMPOUNDS AND THEIR USE AS PI3 KINASE AND mTOR KINASE INHIBITORSWYETH CORP·Filed 2008·Application pending·0 cites
- 2048US10391182B2Bifunctional cytotoxic agentsPFIZER·Filed 2018·Granted Aug 27, 2019·0 cites·8 claims
- 2147US2008233127A1Imidazolopyrimidine analogs and their use as pi3 kinase and mtor inhibitorsWYETH CORP·Filed 2008·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Zecheng Chen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →